Skip to main content

Multiple Myeloma

Breast Cancer, FDA Approvals, In the News, Multiple Myeloma, Pediatric Cancer, Select Drug Profiles
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Read More
FDA Approvals, Multiple Myeloma, In the News, Select Drug Profiles
FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma
Read More
Multiple Myeloma
Elotuzumab, Lenalidomide, and Dexamethasone Combination Demonstrates High Response Rate in High-Risk Smoldering Multiple Myeloma
Chase Doyle
Chase Doyle
Read More
Multiple Myeloma
Pomalidomide Added to the Regimen in First Relapse Extends PFS in Multiple Myeloma
Wayne Kuznar
Read More
Multiple Myeloma
Daratumumab Added to Carfilzomib, Lenalidomide, and Dexamethasone: Safe and Tolerable in Patients with Newly Diagnosed Multiple Myeloma
Chase Doyle
Read More
Multiple Myeloma
CAR T-Cell Immunotherapy Makes Strides in Multiple Myeloma, with Durable Remission
Wayne Kuznar
Read More
Multiple Myeloma
ASCO 2017: Multiple Myeloma Highlights
Read More
Multiple Myeloma
American Society of Hematology 2016: Multiple Myeloma Highlights
Read More
Multiple Myeloma
HIV Drug Shows Promise in Refractory Multiple Myeloma
Charles Bankhead
Read More
Multiple Myeloma
Venetoclax plus Bortezomib and Dexamethasone Produces High Responses in Patients with Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
Read More
Page 2 of 6
Results 11 - 20 of 52